Abstracts

Overview of attention for article published in European Thyroid Journal, August 2016

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

policy: 1 policy source

Readers on

mendeley: 23 Mendeley

So far, Altmetric has seen 2 policy documents that reference this research output.

Cabozantinib for treating medullary thyroid cancer: Committee papers

Cited by National Institute for Health and Care Excellence (NICE) on 16 Aug 2017

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Cabozantinib for treating medullary thyroid cancer: Assessment report

Cited by National Institute for Health and Care Excellence (NICE) on 07 Jun 2017

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.